Hippo signaling in stress response and homeostasis maintenance.
暂无分享,去创建一个
[1] A. Stokes,et al. Concepts of stress , 2017 .
[2] Zengqiang Yuan,et al. BMP2-SMAD Signaling Represses the Proliferation of Embryonic Neural Stem Cells through YAP , 2014, The Journal of Neuroscience.
[3] B. Mao,et al. The alteration of Hippo/YAP signaling in the development of hypertrophic cardiomyopathy , 2014, Basic Research in Cardiology.
[4] Boon Chuan Low,et al. YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth , 2014, FEBS letters.
[5] Shan Jiang,et al. Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer , 2014, Cell.
[6] Patrick Cahan,et al. Hippo Pathway Activity Influences Liver Cell Fate , 2014, Cell.
[7] K. Guan,et al. The Hippo signaling pathway in stem cell biology and cancer , 2014, EMBO reports.
[8] J. Seidman,et al. Cardiac-Specific YAP Activation Improves Cardiac Function and Survival in an Experimental Murine MI Model , 2014, Circulation research.
[9] G. Tonon,et al. RESCUE OF HIPPO CO-ACTIVATOR YAP1 TRIGGERS DNA DAMAGE-INDUCED APOPTOSIS IN HEMATOLOGICAL CANCERS , 2014, Nature Medicine.
[10] E. Sen,et al. Chaetocin-induced ROS-mediated apoptosis involves ATM–YAP1 axis and JNK-dependent inhibition of glucose metabolism , 2014, Cell Death and Disease.
[11] Jianping Fu,et al. Hippo/YAP-mediated rigidity-dependent motor neuron differentiation of human pluripotent stem cells , 2014, Nature materials.
[12] B. Mao,et al. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma , 2014, Oncogene.
[13] Sahar Mansour,et al. Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development , 2013, Nature Genetics.
[14] N. Elvassore,et al. A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors , 2013, Cell.
[15] E. Olson,et al. Hippo pathway effector Yap promotes cardiac regeneration , 2013, Proceedings of the National Academy of Sciences.
[16] Joshua T. Morgan,et al. Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells. , 2013, Experimental eye research.
[17] K. Harvey,et al. Yap controls stem/progenitor cell proliferation in the mouse postnatal epidermis. , 2013, The Journal of investigative dermatology.
[18] F. Camargo,et al. The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense. , 2013, Cell reports.
[19] Robert P. Jenkins,et al. Mechano-transduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer associated fibroblasts , 2013, Nature Cell Biology.
[20] T. Kinashi,et al. Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis , 2013, Proceedings of the National Academy of Sciences.
[21] T. Pawson,et al. Yap- and Cdc42-Dependent Nephrogenesis and Morphogenesis during Mouse Kidney Development , 2013, PLoS genetics.
[22] Christopher J Murphy,et al. Role of substratum stiffness in modulating genes associated with extracellular matrix and mechanotransducers YAP and TAZ. , 2013, Investigative ophthalmology & visual science.
[23] H. Nojima,et al. Yes-associated Protein Isoform 1 (Yap1) Promotes Cardiomyocyte Survival and Growth to Protect against Myocardial Ischemic Injury* , 2012, The Journal of Biological Chemistry.
[24] Satoshi O. Suzuki,et al. Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. , 2012, The Journal of clinical investigation.
[25] D. Lim,et al. Mammalian sterile 20-like kinase 1 suppresses lymphoma development by promoting faithful chromosome segregation. , 2012, Cancer research.
[26] S. Ohsawa,et al. Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila , 2012, Nature.
[27] R. Mann,et al. Control of mitochondrial structure and function by the Yorkie/YAP oncogenic pathway. , 2012, Genes & development.
[28] Xiang-Dong Fu,et al. Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling , 2012, Cell.
[29] Stefano Piccolo,et al. Transduction of mechanical and cytoskeletal cues by YAP and TAZ , 2012, Nature Reviews Molecular Cell Biology.
[30] Jun-bing Wu,et al. Regulation of Neuronal Cell Death by c-Abl-Hippo/MST2 Signaling Pathway , 2012, PloS one.
[31] L. Bubendorf,et al. Abstract 5386: Immunotherapy of bladder cancer using bacillus calmette guérin (BCG): Generation of cytotoxic T-cells is BCG strain dependent , 2012 .
[32] Leah B. Honor,et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy , 2012, Proceedings of the National Academy of Sciences.
[33] F. Camargo,et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance , 2011, Proceedings of the National Academy of Sciences.
[34] John McAnally,et al. Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size , 2011, Science Signaling.
[35] Y. Funato,et al. Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis , 2011, Oncogene.
[36] T. Okano,et al. Hippo pathway regulation by cell morphology and stress fibers , 2011, Development.
[37] P. Northcott,et al. Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation , 2011, Oncogene.
[38] Jun-bing Wu,et al. The c-Abl-MST1 Signaling Pathway Mediates Oxidative Stress-Induced Neuronal Cell Death , 2011, The Journal of Neuroscience.
[39] Nicola Elvassore,et al. Role of YAP/TAZ in mechanotransduction , 2011, Nature.
[40] Randy L. Johnson,et al. Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size , 2011, Science.
[41] O. Kirak,et al. Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation , 2011, Cell.
[42] H. Pasolli,et al. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin , 2011, Proceedings of the National Academy of Sciences.
[43] D. Pan,et al. The hippo signaling pathway in development and cancer. , 2010, Developmental cell.
[44] Ravi A. Desai,et al. Mechanical regulation of cell function with geometrically modulated elastomeric substrates , 2010, Nature Methods.
[45] M. Giovannini,et al. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. , 2010, Genes & development.
[46] M. Giovannini,et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. , 2010, Developmental cell.
[47] Li Li,et al. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. , 2010, Genes & development.
[48] D. Calvisi,et al. The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis , 2010, Proceedings of the National Academy of Sciences.
[49] A. Knebel,et al. JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis , 2010, Cell Death and Disease.
[50] R. M. Simpson,et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression , 2010, Proceedings of the National Academy of Sciences.
[51] Ju-Seog Lee,et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver , 2010, Proceedings of the National Academy of Sciences.
[52] P. Northcott,et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. , 2009, Genes & development.
[53] Mikala Egeblad,et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.
[54] Jeannie T. Lee,et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. , 2009, Cancer cell.
[55] G. Michalopoulos,et al. Enhanced liver regeneration following changes induced by hepatocyte‐specific genetic ablation of integrin‐linked kinase , 2009, Hepatology.
[56] H. Aburatani,et al. Transcriptional coactivator with PDZ-binding motif is essential for normal alveolarization in mice. , 2009, American journal of respiratory and critical care medicine.
[57] A. McClatchey,et al. Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma , 2009, Proceedings of the National Academy of Sciences.
[58] P. Pandolfi,et al. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. , 2008, Molecular cell.
[59] F. Gage,et al. YAP regulates neural progenitor cell number via the TEA domain transcription factor. , 2008, Genes & development.
[60] W. Tao,et al. Lats2 Is a Negative Regulator of Myocyte Size in the Heart , 2008, Circulation research.
[61] Y. Kong,et al. A crucial role of WW45 in developing epithelial tissues in the mouse , 2008, The EMBO journal.
[62] G. Yan,et al. Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells. , 2008, Cancer research.
[63] D. Flagiello,et al. SCALLOPED Interacts with YORKIE, the Nuclear Effector of the Hippo Tumor-Suppressor Pathway in Drosophila , 2008, Current Biology.
[64] H. Aburatani,et al. Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. , 2008, American journal of physiology. Renal physiology.
[65] R. Jaenisch,et al. YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells , 2007, Current Biology.
[66] Steffen Hauptmann,et al. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma , 2007, Molecular carcinogenesis.
[67] G. Feldmann,et al. Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.
[68] D. Albertson,et al. DNA profiling of primary serous ovarian and Fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation‐dependent probe amplification , 2007, The Journal of pathology.
[69] M. Yaffe,et al. TAZ Promotes PC2 Degradation through a SCFβ-Trcp E3 Ligase Complex , 2007, Molecular and Cellular Biology.
[70] J. Sadoshima,et al. Inhibition of Endogenous Mst1 Prevents Apoptosis and Cardiac Dysfunction Without Affecting Cardiac Hypertrophy After Myocardial Infarction , 2007, Circulation research.
[71] Jay Z. Parrish,et al. Polycomb genes interact with the tumor suppressor genes hippo and warts in the maintenance of Drosophila sensory neuron dendrites. , 2007, Genes & development.
[72] Y. Shaul,et al. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73 , 2007, Cell Death and Differentiation.
[73] K. Harvey,et al. The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network , 2007, Nature Reviews Cancer.
[74] H. Ko,et al. Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1 , 2007, Proceedings of the National Academy of Sciences.
[75] D. Goldstein,et al. Evolution of concepts of stress , 2007, Stress.
[76] Wei Zhou,et al. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma , 2006, Neuroscience Research.
[77] S. Sen,et al. Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.
[78] M. Wigler,et al. Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic Approach , 2006, Cell.
[79] Judit Villén,et al. A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life Span , 2006, Cell.
[80] M. Sheetz,et al. Local force and geometry sensing regulate cell functions , 2006, Nature Reviews Molecular Cell Biology.
[81] S. Jhanwar,et al. A mouse model recapitulating molecular features of human mesothelioma. , 2005, Cancer research.
[82] Jianbin Huang,et al. The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP , 2005, Cell.
[83] J. Fridlyand,et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.
[84] Robert Tibshirani,et al. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. , 2005, Neoplasia.
[85] Ying Li,et al. Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats , 2005, Cell.
[86] Y. Miyoshi,et al. Down-Regulation of LATS1 and LATS2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers , 2005, Clinical Cancer Research.
[87] M. Yaffe,et al. TAZ Interacts with TTF-1 and Regulates Expression of Surfactant Protein-C* , 2004, Journal of Biological Chemistry.
[88] J. Epstein,et al. Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3 , 2004, Development.
[89] I. Hariharan,et al. The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis , 2003, Cell.
[90] S. Vatner,et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. , 2003, The Journal of clinical investigation.
[91] Wei-Guo Zhu,et al. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. , 2003, Human molecular genetics.
[92] P Robin Hiesinger,et al. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila , 2002, Development.
[93] D. Haber,et al. salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines , 2002, Cell.
[94] M. Perricaudet,et al. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. , 2002, Genes & development.
[95] C. Haipek,et al. Functional analysis of neurofibromatosis 2 (NF2) missense mutations. , 2001, Human molecular genetics.
[96] A. Berns,et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. , 2000, Genes & development.
[97] W. Tao,et al. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction , 1999, Nature Genetics.
[98] T. Jacks,et al. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. , 1998, Genes & development.
[99] P J Bryant,et al. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. , 1995, Genes & development.
[100] J. Avruch,et al. Mst 1 and Mst 2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap 1 Oncogene , 2011 .
[101] M. Gibson,et al. Cell topology, geometry, and morphogenesis in proliferating epithelia. , 2009, Current topics in developmental biology.
[102] Y. Miyoshi,et al. Down-Regulation of LATS 1 and LATS 2 mRNA Expression by Promoter Hypermethylation and Its Association with Biologically Aggressive Phenotype in Human Breast Cancers , 2005 .